ResearchA Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors
ResearchGenomic alterations associated with early-stage disease and early recurrence in patients with colorectal cancer
ResearchLong-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials
ResearchA phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors
ResearchSevere Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation
ResearchIncorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group
ResearchGenetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal Cancer
ResearchAuthors' Reply to the Letter to the Editor by Kim et al: Are We Asking the Right Question for New Biomarkers
ResearchQualitative study of patient and caregiver experiences during multimodality treatment for locally advanced rectal cancer
ResearchA blueprint for creating an early-onset colorectal cancer program based on experiences from 7 clinical centers across the United States and Canada
ResearchOpen-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer
ResearchFeasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients With Pancreatic Ductal Adenocarcinoma
ResearchCollagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies